Company Filing History:
1 out of 8,384 
1 out of 818 
1 out of 2,968 
Years Active: 2022
Title: Prerna Saluja Bhargava: Innovator in Engineered Phagemids
Introduction
Prerna Saluja Bhargava is a notable inventor based in Watertown, MA (US). She has made significant contributions to the field of synthetic biology, particularly through her innovative work on engineered phagemids. Her research focuses on developing advanced genetic circuits that can have a profound impact on antimicrobial therapies.
Latest Patents
Prerna holds a patent for her invention titled "Engineered Phagemids." This patent describes engineered phagemids that incorporate at least one synthetic genetic circuit. The synthetic genetic circuit includes gene sequences encoding non-lytic antimicrobial peptides (AMPs) and/or antibacterial toxin proteins. Additionally, the engineered phagemid features a stable origin of replication and a bacteriophage-packaging signal. Importantly, it does not contain some or all gene sequences encoding bacteriophage proteins necessary for the assembly of a bacteriophage particle.
Career Highlights
Throughout her career, Prerna has worked with prestigious institutions such as the Massachusetts Institute of Technology and Boston University. Her work in these environments has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Prerna has collaborated with notable individuals, including Russell-John Krom and James Joseph Collins. These partnerships have further enhanced her research and innovation in synthetic biology.
Conclusion
Prerna Saluja Bhargava is a pioneering inventor whose work on engineered phagemids represents a significant advancement in the field of synthetic biology. Her contributions are poised to influence future developments in antimicrobial therapies and genetic engineering.